The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

In­di­a's Glen­mark Phar­ma­ceu­ti­cals di­vests 75% stake in its API man­u­fac­tur­ing sub­sidiary

7 hours ago
R&D

Q&A: No­vo Nordisk Foun­da­tion’s Celler­a­tor CEO Thomas Carlsen digs in­to $135.4M Dan­ish cell ther­a­py fa­cil­i­ty

Yesterday
Cell/Gene Tx

In new draft guid­ance for man­u­fac­tur­ing in­spec­tions, FDA draws in­spi­ra­tion from pan­dem­ic meth­ods

Yesterday
FDA+

Sam­sung Bi­o­log­ics locks $242M BMS deal; Fu­ture Fields launch­es CD­MO arm; SK pharmte­co takes con­trol of CBM

Yesterday

Up­dat­ed: So­ci­etal CD­MO lays off 26 em­ploy­ees, re­works hir­ing plans af­ter strat­e­gy re­view

Yesterday
People

Look­ing for an edge in a com­pet­i­tive mar­ket, Ox­ford Nanopore moves in­to mR­NA vac­cine test­ing

Yesterday
Outsourcing

No­vo Nordisk’s US semaglu­tide man­u­fac­tur­ing site un­der the spot­light again as 2022 mon­i­tor­ing is­sue sur­faces

Yesterday
Pharma

Mod­er­na de­creas­es mR­NA pro­duc­tion with Lon­za in Switzer­land, brings some man­u­fac­tur­ing in-house

2 days ago
Pharma

Ox­ford Bio­med­ica piv­ots by lay­ing off 200 peo­ple, ac­quir­ing ABL Eu­rope amid de­clin­ing to­tal rev­enues

2 days ago
People

NightHawk lays off 14% of R&D work­force, piv­ots to fo­cus on CD­MO Scor­pius Bio­man­u­fac­tur­ing

2 days ago
People

Ther­mo Fish­er is ready to ex­pand its vi­ral vec­tor pro­duc­tion site in Mass­a­chu­setts once there’s ‘de­mand for it’

2 days ago
Pharma

Chi­nese im­ports of com­mon can­cer drug run dry, FDA says

2 days ago
FDA+

Rentschler names Benedikt von Braun­muehl as CEO; Catal­ent grabs David McEr­lane from Lon­za as bi­o­log­ics lead

3 days ago
People

CDER di­rec­tor urges man­u­fac­tur­ers to work with FDA to fix in­spec­tion is­sues be­fore shut­ting down

4 days ago
Pharma
FDA+

CD­MOs Nephron and Can­ton each raise hun­dreds of mil­lions in fi­nanc­ing

4 days ago
Financing

Lon­za CEO Pierre-Alain Ruffieux to leave CD­MO amid re­duced growth

4 days ago
People

Bris­tol My­er­s' man­u­fac­tur­ing shut­down means low­er-than-ex­pect­ed Q3 sales for Abec­ma

Last week
Pharma

Why End­points is bring­ing a new fo­cus to our man­u­fac­tur­ing cov­er­age

Last week
Editor's note

Astel­las ear­marks $354.2M for Irish build; Sam­sung Bi­o­log­ics get in­to AD­Cs; Rentschler gets UK fa­cil­i­ty ap­proved

Last week

Q&A: Lon­za CGT pres­i­dent Daniel Pal­mac­ci talks man­u­fac­tur­ing amid low­er sales out­look

Last week
Cell/Gene Tx

FDA makes some strides in eas­ing US can­cer drug sup­ply short­ages by work­ing with man­u­fac­tur­ers

Last week
FDA+

MaaT Phar­ma and CD­MO Skyephar­ma un­veil be­spoke, and po­ten­tial­ly largest, mi­cro­bio­me fa­cil­i­ty in Eu­rope

Last week
R&D

No­var­tis is­sues vol­un­tary re­call of oral cy­closporine Sandim­mune due to crys­tal­liza­tion con­cerns

Last week
FDA+

Roche to re­file sub­cu­ta­neous Tecen­triq ap­pli­ca­tion with FDA be­fore year’s end on the back of man­u­fac­tur­ing tweaks

Last week
FDA+
1234 Next page Last page
A service from the Financial Times